Sun Pharma Canada Inc., a wholly owned subsidiary of Sun Pharmaceutical Industries Limited ("Sun Pharma"), is pleased to announce the availability of ILUMYA (tildrakizumab) Pen, a self-administered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback